Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Bind Therapeutics, an oncology nanomedicine drug discovery company, and its affiliate Bind Biosciences Security Corp., have filed a reorganization petition in the U.S. Bankruptcy Court for the District of Delaware. CEO Andrew Hirsch says the filing will give the firm time to reorganize while continuing collaborations with Pfizer and AstraZeneca. Financial backers for the firm include David H. Koch’s DHK Investment and Polaris Partners.
This article has been sent to the following recipient: